IMDX
Financials
- Market Capitalization 137.44 M
- Employee 58
- Founded 2009
- CEO N/A
- Website www.imdxinc.com
- Headquarter California, United States
- FIGI BBG008P5VFV1
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3542 |  STIM Neuronetics, Inc. - Common Stock | 2.94 USD | -0.68% | -2.00% | +58.06% | -15.03% | 224.02 M USD | ||
| 3684 |  XGN Exagen Inc. - Common Stock | 7.38 USD | -1.86% | -6.82% | +65.47% | -24.39% | 178.78 M USD | ||
| 3892 |  BNR Burning Rock Biotech Limited - American Depositary Shares | 10.19 USD | +1.90% | -1.26% | +14.37% | -65.94% | 110.26 M USD | ||
| 4148 |  DRIO DarioHealth Corp. - Common Stock | 6.82 USD | -2.01% | -10.03% | -12.34% | -38.94% | 66.83 M USD |
Frequently asked questions about Insight Molecular Diagnostics Inc. Common Stock
What is the Insight Molecular Diagnostics Inc. Common Stock stock price today?
The current price of Insight Molecular Diagnostics Inc. Common Stock (IMDX) is 4.20. Over the past 24 hours, the stock has changed by -2.10%. Follow the IMDX chart for real-time price dynamics.
What is the stock ticker of Insight Molecular Diagnostics Inc. Common Stock?
Insight Molecular Diagnostics Inc. Common Stock trades under the ticker IMDX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Insight Molecular Diagnostics Inc. Common Stock stock going up?
IMDX has changed by -4.11% over the last week, -8.50% over the last month, and +67.40% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Insight Molecular Diagnostics Inc. Common Stock?
Insight Molecular Diagnostics Inc. Common Stock currently has a market capitalization of 137.44 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Insight Molecular Diagnostics Inc. Common Stock earnings last quarter?
Last quarter, Insight Molecular Diagnostics Inc. Common Stock reported earnings of -0.31 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Insight Molecular Diagnostics Inc. Common Stock revenue for the last quarter?
Insight Molecular Diagnostics Inc. Common Stock reported quarterly revenue of 219 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Insight Molecular Diagnostics Inc. Common Stock net income for the last quarter?
Insight Molecular Diagnostics Inc. Common Stock reported net income of -11.26 M for the last quarter. The previous quarter showed -4.29 M, which means net income changed by -162.47%.
How many employees does Insight Molecular Diagnostics Inc. Common Stock have?
As of the latest available data, Insight Molecular Diagnostics Inc. Common Stock has 58 employees. Workforce size can provide additional context about the company's scale and operations.
What is Insight Molecular Diagnostics Inc. Common Stock EBITDA?
Insight Molecular Diagnostics Inc. Common Stock EBITDA is -10.76 M, and its EBITDA margin is -4 911.87%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Insight Molecular Diagnostics Inc. Common Stock stock?
You can buy Insight Molecular Diagnostics Inc. Common Stock (IMDX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Insight Molecular Diagnostics Inc. Common Stock stock?
Investing in Insight Molecular Diagnostics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMDX chart and related analysis on metatrader.com as part of your research.